Aspen Aerogels, Inc. reported $202M of revenue over the trailing twelve months, −49% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $202M (to Q2 2026). Net income: −$126M, trailing twelve months to Q2 2026. Free cash flow: $34M, trailing twelve months to Q2 2026. Operating margin: −72%, trailing twelve months to Q2 2026.

ASPNAspen Aerogels, Inc.

Industrials

$5.62-30% 1Y

$5.62

$2.5752 weeks$8.82

ASPN as reported

Aspen Aerogels, Inc. reported $202M of revenue over the trailing twelve months, −49% on the year before. 10 reported series are charted on this page, each one as filed.

$202M

Revenue, trailing twelve months · to Q2 2026 · −49% against the twelve months before

Net income: −$126M
Net income · −60% year on year · trailing twelve months to Q2 2026
Free cash flow: $34M
Free cash flow · −1142% year on year · trailing twelve months to Q2 2026
Operating margin: −72%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ASPN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$202M	−49%	Q2 2026
Net income	−$126M	−60%	Q2 2026
EPS	−$1.53	−60%	Q2 2026
Gross margin	−2.3%	n/a	Q2 2026
Operating margin	−72%	n/a	Q2 2026
Net margin	−74%	n/a	Q2 2026
ROE	−96%	n/a	Q2 2026
ROA	−54%	n/a	Q2 2026
ROIC	−122%	n/a	Q2 2026
Free cash flow	$34M	−1142%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.